Posts in tag

drug trials

An Australian-led global study investigating a treatment for colorectal cancer has shown the treatment provides significant benefit, a major gathering of oncologists have been told.

A major study of patients with type 2 diabetes and established cardiovascular disease has found that a DPP-4 inhibitor does not increase the risk for major adverse CV events, hospitalisation for heart failure or adverse events

The IMPROVE-IT study, the large cardiovascular-outcomes trial that showed a clinical benefit to adding ezetimibe to statin therapy in post–acute coronary syndrome patients, is now published.